A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence

Clinical trial NCT05674045 · COMPLETED

Trial details

NCT number: NCT05674045
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stress Urinary Incontinence

Start date: 2022-01-06
Primary completion: 2022-01-06
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.